Singlehurst, Peter (Baillie Gifford 201511 Investment Analyst) |
Analyst (Financial / Industry) |
Baillie Gifford |
United Kingdom (GB) |
Sinha, Vikas (ElevateBio 201905 CFO formerly Alexion + Bayer Pharmaceuticals Corp) |
Chief Financial Officer (CFO) |
ElevateBio (Group) |
United States (USA) |
Sinz, Andrea (Univ Halle 2010 Prof Institute for Pharmacy + 201702 President of DGMS) |
Professor |
University of Halle (Martin-Luther Universität Halle-Wittenberg) |
Germany |
Siodla, Vilma (Co.don 201202 COO) |
Chief Operating Officer (COO) |
ReLive (Group) |
Germany |
Sirinakis, Kyp (Epidarex Capital 201701 Managing Partner before Rock Spring Ventures) |
Managing Partner (investment firm) |
Epidarex Capital (Group) |
United Kingdom (GB) |
Sirk, Kimberley (Cytel 202309 Senior Director Content + Communications) |
Public Relations Manager / Investor Relations Manager |
Cytel (Group) |
United States (USA) |
Sitkovsky, Michail (RedoxTherapies Founder) |
Company Founder |
Bristol Myers Squibb (BMS) (Group) |
United States (USA) |
Sjöström, Michael |
n. a. |
Pictet (Group) |
Switzerland |
Skentelbery, Claire (EuropaBio 202011– Director General before nia + CEBR + EBF) |
Cluster Manager |
EuropaBio aisbl – the European Association of Bioindustries |
Belgium |
Skerjanec, Simona (Immunic 202407– Board Director has been at Roche + The Medicines Company + Lilly + JnJ) |
Board member, non-executive |
Immunic (Group) |
United States (USA) |
Skerra, Arne (XL-protein GmbH 201104 Managing Director) |
Managing Director |
XL-protein GmbH (XLp) |
Germany |
Skinner, Henry (Tekla Capital 202005 before Novartis 201201 Managing Director of Novartis Venture Fund) |
Managing Director |
Tekla Capital Management LLC |
United States (USA) |
Skorka, Kaja (MC Services 201903 Consultant) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
Skullerud, Erik (Nordic Nanovector 202109– CEO before Element Consulting GmbH + Amgen + Bayer) |
Chief Executive Officer (CEO) |
Nordic Nanovector (Group) |
Norway |
Slack, David (Novimmune 201402 Head Corporate + Business Development LEFT 9/14) |
Business Development Manager / Strategy Manager |
Novimmune S.A. |
Switzerland |
Slack, Mark (Evotec 200905 Senior Scientist) |
Researcher (industry) |
Evotec (Group) |
Germany |
Slade, Andrew (Menarini 201303 President of Menarini Biologics) |
President/Director/Head Business Group/Unit/Division |
Menarini (Group) |
Italy |
Sladek, Barbara (Biome Diagnostics 202301 Managing Director + Co-Founder) |
Managing Director |
Biome Diagnostics GmbH |
Austria |
Slaoui, Moncef (GSK –201707 Chairman Vaccines TO RETIRE 6/17) |
President/Director/Head Business Group/Unit/Division |
GSK (Group) |
United Kingdom (GB) |
Slawinski, Kristen (Chempetitive 201506) |
Public Relations Manager / Investor Relations Manager |
CG Life (Group) |
United States (USA) |
Sleight, Andrew (AB2 Bio 201602 CEO before 21y at Roche) |
Chief Executive Officer (CEO) |
AB2 Bio S.A. |
Switzerland |
Slikker, William, Jr., PhD (FDA 200601) |
n. a. |
Merck (DE) (Group) |
Germany |
Slingsby, Jason (LifeArc 202305– CBO before Oxford Biomedica + Miti Biosystems + ProtAffin) |
Business Development Manager / Strategy Manager |
LifeArc (GB) |
United Kingdom (GB) |
Slobod, Karen (CureVac 201509– Managing Director of new US subsidiary before at Novartis Vaccines) |
Managing Director |
CureVac (Group) |
United States (USA) |
Slootweg, Sander (Forbion Capital Partners 20111 Managing Partner before ABN AMRO Capital) |
Managing Partner (investment firm) |
Forbion (Group) |
Netherlands |
Slot, Reinout (CMS Derks Star Busman 201511) |
Attorney / Lawyer |
CMS (Group) |
Netherlands |
Smedegaard, Peter (Syddansk Innovation 201809 investment + Portfolio Manager) |
Investment Manager |
Syddansk Innovation (SDI) |
Denmark |
Smedley, Mark (Life Technologies 201008 Head Asia Pacific region before Invitrogen before Novartis) |
Regional manager |
Thermo Fisher (Group) |
United States (USA) |
Smets, Martha (Life Science Venture Fund 202302 Investment Director + Blue Ribbon Partners 202302 Venture Partner) |
Investment Manager |
Life Science Valley (Sartorius / Niedersachsen/ Univ Göttingen) (Group) |
Germany |
Smettan, Gerhard (AZ Biopharm 201105 Business Development) |
Business Development Manager / Strategy Manager |
Analytisches Zentrum Biopharm GmbH Berlin (AZ Biopharm) |
Germany |
Smit, Ralf (Eleva 202101– CBO before advisor to Eleva + at BioStrat + Roche) |
Chief Business Officer (CBO) |
Eleva GmbH |
Germany |
Smith, Adrian (Sysmex 202204– CEO of Oxford Gene Technology before Hologic UK/IE + Qiagen + Roche) |
Chief Executive Officer (CEO) |
Sysmex (Group) |
United Kingdom (GB) |
Smith, Andrew (GeneBio 200503 Marketing Manager) |
Sales Manager / Marketing Manager |
GeneBio (Group) |
Switzerland |
Smith, Andrew (Santhera 202004– CFO before Allecra Therapeutics + Sucampo Pharmaceuticals) |
Chief Financial Officer (CFO) |
Santhera (Group) |
Switzerland |
Smith, Angus (Affimed 202007– CFO based in US before Rockwell Medical + Pernix Therapeutics + Cantor Fitzgerald) |
Chief Financial Officer (CFO) |
Affimed (Group) |
Germany |
Smith, Brendan (CRISPR Therapeutics 202110–202303 CFO before Translate Bio + Boston Consulting + Pfizer LEFT 3/23) |
Chief Financial Officer (CFO) |
CRISPR Therapeutics (Group) |
Switzerland |
Smith, David (Lonza 201502 Head of Cell Therapy, Lonza Custom Manufacturing) |
President/Director/Head Business Group/Unit/Division |
Lonza (Group) |
United States (USA) |
Smith, David R. (Galapagos 201308– CFO/CEO services division before Cambridge Univ Hospitals + Galapagos + AstraZeneca) |
Chief Financial Officer (CFO) |
Galapagos (Group) |
Belgium |
Smith, Erin (PAN Communications 201908) |
Public Relations Manager / Investor Relations Manager |
PAN Communications (Boston) |
United States (USA) |
Smith, John (Peak Scientific 201304 Head of Gas) |
n. a. |
Peak Scientific (Group) |
United Kingdom (GB) |
Smith, Jonathan (PaxVax 201609 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
PaxVax (Group) |
United States (USA) |
Smith, Marcus (Recipharm 202202 Head of Communications) |
Public Relations Manager / Investor Relations Manager |
Recipharm (Group) |
Sweden |
Smith, Paul (Axela 201605 President) |
President/Director/Head Business Group/Unit/Division |
Axela Inc. |
Canada |
Smith, Richard E. T. (StrideBio 201704 Director Operations) |
Chief Operating Officer (COO) |
StrideBio Inc. |
United States (USA) |
Smith, Scott A. (Viatris 202402 CEO) |
Chief Executive Officer (CEO) |
Viatris (Group) |
United States (USA) |
Smith, Sean R. (ImmunOs Therapeutics 201912 CEO) |
Chief Executive Officer (CEO) |
Immunostep (ES) |
Spain (España) |
Smith, Trevor (Takeda –201503 Takeda Pharmaceuticals International GmbH LEFT 3/15 |
n. a. |
Takeda (Group) |
Switzerland |
Smits, Philip (Schering AG 200510) |
n. a. |
Bayer (Group) |
Germany |
Snyder, Scott (Evotec 201304 EVP Compound Management) |
President/Director/Head Business Group/Unit/Division |
Evotec (Group) |
Germany |
Soenksen, Dirk G. (Aperio 201105 CEO) |
Chief Executive Officer (CEO) |
Danaher (Group) |
United States (USA) |
Sohier, Daniele (Bruker 201802 Business Development Manager for Industrial Microbiology at Bruker Daltonics) |
Business Development Manager / Strategy Manager |
Bruker (Group) |
United States (USA) |
Sohler, Matthias (Yabeo Capital GmbH 202002 Managing Director + Founder) |
Managing Director |
Yabeo Capital GmbH |
Germany |
Soignet, Steven L. (Arcus Ventures 2007– General Partner + Co-founder) |
General Partner (venture partner) |
Arcus Ventures |
United States (USA) |
Sojeva, Brittney (MC Services 202101) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
Sokolov, Michael (DataHow 202409 COO + Co-Founder) |
Chief Operating Officer (COO) |
DataHow AG |
Switzerland |
Sola, Josep (Aktiia 201805– CTO + Co-Founder) |
Chief Technology/Technical Officer (CTO) |
Aktiia S.A. |
Switzerland |
Soldan, Michael (Polpharma Biologics 202208 CEO) |
Chief Executive Officer (CEO) |
Polpharma (Group) |
Poland |
Soldo, Josh (Anteo Technologies 201507 VP Sientific Affairs) |
Research & Development Manager |
Anteo Technologies (AU) |
Australia |
Solibieda, Markus (BASF 201902 Managing Director at BASF Venture Capital) |
Managing Director |
BASF (Group) |
Germany |
Solis, Victor (EpiQMAx GmbH 201903 Managing Director + Co-Founder) |
Managing Director |
EpiQMAx GmbH |
Germany |
Soll, Michael (LECO 201106 Managing Director of LECO Instrumente GmbH) |
Managing Director |
Leco (Group) |
Germany |
Solntseva, Olga (BioLine LLC 201310 Director Sales + Marketing for Diagnostic Products) |
Sales Manager / Marketing Manager |
BioLine LLC (RU) |
Russian Federation |
Solomon, David Horn (Mithra Pharmaceuticals 202304– before Pharnext+ Silence Tx + Zealand Pharma + Bionor Pharma) |
Chief Executive Officer (CEO) |
Mithra Pharmaceuticals (Group) |
Belgium |
Soloway, Thomas M. (P.) (Tom) (T-Knife 202101– CEO before Audentes Tx + Ascendis Pharma + Transcept Pharmaceuticals) |
Chief Executive Officer (CEO) |
T-Knife (Group) |
United States (USA) |
Sommer, Bernd (Boehringer Ingelheim 201312 Head of Neuroscience Research) |
Research & Development Manager |
Boehringer Ingelheim (Group) |
Germany |
Sommer, Kuno (200512 Berna Biotech CEO) |
Chief Executive Officer (CEO) |
Johnson & Johnson (JnJ) (Group) |
Switzerland |
Sommer, Wieland (Smart Reporting 202404 Co-CEO + Founder) |
Chief Executive Officer (CEO) |
Smart Reporting GmbH |
Germany |
Sommerfeld, Franziska (LGC 201009 LGC Genomics GmbH) |
Public Relations Manager / Investor Relations Manager |
LGC (Group) |
Germany |
Somogyi, Gabor (EveliQure Biotechnologies 202003 CEO) |
Chief Executive Officer (CEO) |
EveliQure Biotechnologies GmbH |
Austria |
Sondermann, Peter (Tacalyx 201909 CEO before Shire + Baxalta + SuppreMol + Roche + Glycart Biotechnology) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Tacalyx GmbH |
Germany |
Song, Ken (Candid Tx 202409 CEO + Co-Founder before RayzeBio + Metacrine + Ariosa Diagnostics + Venrock + McKinsey) |
Chief Executive Officer (CEO) |
Candid Therapeutics (Group) |
United States (USA) |
Song, Yan (Link Health 201605 CEO) |
Chief Executive Officer (CEO) |
Link Health (CN) (Group) |
China |
Songhurst, Charlie |
n. a. |
|
|
Sonntag, Denise (Biocrates 201203 Director of Contract Research) |
President/Director/Head Business Group/Unit/Division |
Biocrates (Group) |
Austria |
Sontschek, Erwin (Mikrogen 2003) |
n. a. |
Mikrogen GmbH |
Germany |
Sood, Nitin (Qiagen 202401 SVP Head Life Science Business Area formerly NuGen + PerkinElmer + Boreal Genomics + Agilent) |
President/Director/Head Business Group/Unit/Division |
Qiming (Group) |
China |
Soon-Shiong, Patrick (Abraxis BioSiences 200604 CEO) |
Chief Executive Officer (CEO) |
Bristol Myers Squibb (BMS) (Group) |
United States (USA) |
Soriot, Pascal (AstraZeneca 201210– CEO before Roche COO Pharma Div before Genentech CEO) |
Chief Executive Officer (CEO) |
AstraZeneca (Group) |
United Kingdom (GB) |
Soroka, Joanna (Hitachi 202403 Principal at Hitachi Ventures GmbH) |
Principal (venture capital) |
Hitachi (Group) |
Germany |
Soto, Alvaro (Roche 201402 CEO of Roche Servicios) |
Chief Executive Officer (CEO) |
Roche (Group) |
|
Soudagar, Yasaman (Neurescence 202211 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Bruker (Group) |
Canada |
Soug, Øystein (Targovax 201809 CEO before CFO sind 201506 before Algeta + Orkla Group) |
Chief Executive Officer (CEO) |
Circio (Group) |
Norway |
Soula, Gérard (Adocia 201201 CEO + co-founder also founder of Flamel Technologies) |
Chief Executive Officer (CEO) |
Adocia S.A. |
France |
Soula, Olivier (Adocia 2005 co-founder) |
Company Founder |
Adocia S.A. |
France |
Soutschek, Erwin (Mikrogen 201007 Managing Director + Co-founder) |
Managing Director |
Mikrogen GmbH |
Germany |
Souza, Jeff (BioBridges 201709 CEO) |
Chief Executive Officer (CEO) |
Adecco (Group) |
United States (USA) |
Spaggiari, Stefano (Expert System 201505 CEO) |
Chief Executive Officer (CEO) |
Expert System (Group) |
United States (USA) |
Sparkman, O. David (Univ of the Pacific 1999–201005– Adjunct Professor + Mass-Spec-Training.com) |
Professor |
University of the Pacific |
United States (USA) |
Spatscheck, Reinhilde (SHS 201807 Managing Partner) |
Managing Partner (investment firm) |
SHS Capital (Group) |
Germany |
Spatz, Daniel (CellGenix 202104– VP Sales, Marketing + Logistics before PromoCell + Becton Dickinson) |
Sales Manager / Marketing Manager |
Becton, Dickinson (Group) |
Germany |
Specht (formerly Mannagottera), Lisa (Qiagen 202409 Manager Public Relations) |
Public Relations Manager / Investor Relations Manager |
Qiagen (Group) |
Germany |
Speich, Norbert (IMoGen GmbH 201104 Managing Director) |
Managing Director |
IMogen Institut für Molekularpathologie und Gendiagnostik GmbH |
Germany |
Speidel, Daniel (Breakpoint Therapeutics 201907 Managing Director) |
Managing Director |
Breakpoint Therapeutics GmbH |
Germany |
Speier, Austin (Click Therapeutics 202212 Chief Strategy Officer) |
Business Development Manager / Strategy Manager |
Click Therapeutics Inc. |
United States (USA) |
Speir, Paul (Bruker 200905 VP FTMS Bruker Daltonics) |
Research & Development Manager |
Merck (US) (MSD) (Group) |
United States (USA) |
Speiser, Dieter K. |
n. a. |
Eisenführ Speiser Patentanwälte Rechtsanwälte PartGmbB |
Germany |
Spek, Hanspeter (sanofi-aventis 2007 Executive VP Pharmaceutical Operations) |
n. a. |
Sanofi (Group) [since May 2011] |
France |
Spelta, Michele (Mediolanum 201612 Business Development Manager) |
Business Development Manager / Strategy Manager |
Mediolanum (Group) |
Italy |
Spencer, Ryan (Dynavax 202004 CEO) |
Chief Executive Officer (CEO) |
Dynavax (Group) |
United States (USA) |
Spengler, Bernhard (Univ Giessen 201007 Professor Inorganic + Analytical Chemistry) |
Professor |
University of Gießen (Justus Liebig University) |
Germany |